SGLT2 Inhibitors Decrease Overhydration and Proteasuria in Patients with Chronic Kidney Disease: A Longitudinal Observational Study

• Main Authors: Anja Schork (Author), Marie-Luise Eberbach (Author), Bernhard N. Bohnert (Author), Matthias Wörn (Author), David J. Heister (Author), Felix Eisinger (Author), Elisabeth Vogel (Author), Nils Heyne (Author), Andreas L. Birkenfeld (Author), Ferruh Artunc (Author)
• Format: Book
• Published: Karger Publishers, 2024-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Introduction: SGLT2 inhibitors are used to reduce the risk of progression of chronic kidney disease (CKD). In patients with type 2 diabetes, they have been found to reduce extracellular volume. Given the high prevalence of extracellular volume expansion and overhydration (OH) in CKD, we investigated...